| Market Closed - Nasdaq 17:16:01 2024-07-16 EDT | 5-day change | 1st Jan Change | ||
| 18,509 PTS | +0.20% |
|
+0.43% | +23.30% |
| 07-16 | Apollomics Gets 180-Day Extension to Meet Nasdaq Listing Requirement | MT |
| 07-16 | Equity Markets Higher After Retail Sales Report, Earnings | MT |
Jan 28 (Reuters) - Shares of private equity firm Carlyle Group Inc-backed Ortho Clinical Diagnostics fell 8.8% in their Nasdaq debut on Thursday, giving the Raritan, New Jersey-based diagnostics company a market capitalization of $3.36 billion.
(Reporting by Amruta Khandekar in Bengaluru; Editing by Vinay Dwivedi)
Highest NASDAQ Composite increases |
|
|---|---|
| +16.57% | |
| +15.50% | |
| +15.47% | |
| +14.96% | |
| +13.38% |
The sharpest declines in NASDAQ Composite. |
|
|---|---|
| -3.97% | |
| -5.71% | |
| -6.44% | |
| -9.09% | |
| -9.21% |
NASDAQ COMPOSITE 
